Home | Articles
Published on:March 2021
Indian Journal of Pharmaceutical Education and Research, 2021; 55(1s):s29-s47
Review Article | doi:10.5530/ijper.55.1s.35

Natural Chimeras of Existing Drugs for Alzheimer’s Disease: Expanding the Target Landscape

Authors and affiliation (s):

Illham Dhala, Tabassum Khan, Arati Prabhu*

Department of Pharmaceutical Chemistry and Quality Assurance, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, Maharashtra, INDIA.


Alzheimer’s disease (AD) has emerged as a complex, multi-faceted, neurodegenerative disorder. Multiple mechanisms seem to play a part in its pathogenesis, including amyloid beta aggregation, cholinergic deficit, oxidative stress and neuroinflammation. The current FDA-approved anticholinesterase drugs addressing a single mechanism have turned out to be palliative rather than curative. A number of natural medicinal bioactive are known, which have the potential to overcome many of the unaddressed causal mechanisms contributing to AD. They act as excellent antioxidants, metal chelators, anti-inflammatory mediators and are neuroprotectives. Natural products also have the inherent capability of overcoming some of the adverse effects caused by the currently available drugs. Several researchers have worked on the development of chimeric compounds for AD, in which known cholinesterase inhibitors are linked with natural bioactive components. The resulting novel molecular entities formed have been shown to simultaneously modulate multiple targets with higher efficacy and better safety profiles, demonstrated in experimental models. This review presents a compilation and rational analysis of several natural chimeras of known anti-AD drugs, explored to expand the efficacy and safety profile of current FDA-approved anti-Alzheimer’s medications.

Key words: Alzheimer disease, Natural bioactives, Cholinesterase inhibitors, Antioxidants, Chimeric compounds, Hepatotoxic.




Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).


Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs